Healthcare & Life Sciences
GeNeuro
Switzerlandgen-europe.org
GeNeuro is a series a startup. 1 investor tracked.
Activeseries-a
series-a
Stage
1
Investors
About GeNeuro
GeNeuro is a startup based in Switzerland. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
GeNeuro is a clinical-stage biopharmaceutical company focused on developing treatments for neurodegenerative and autoimmune diseases by targeting human endogenous retroviruses (HERVs). Its lead candidate, temelimab, is a monoclonal antibody designed to neutralize pathogenic proteins associated with conditions like multiple sclerosis, amyotrophic lateral sclerosis, and post-COVID neuropsychiatric syndromes.
Explore GeNeuro's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.